The team identified a protein called NaV1.9 present in nerves associated with pain which is essential for their activation in the laboratory. The work was published in PAIN the official journal of the International Association for the Study of PainNaV1.9 is now considered an important approach to the treatment of pain in Crohn’s disease. 

The study on pain in IBD (Ulcerative Colitis and Crohn's disease) under the supervision of Dr David Bulmer recorded the first ever recording of pain receptors in the human gut and gone on to further detail how these function in the gut in health and disease.

Without Bowel & Cancer Research funding this project would not have made it past the conception stage.

This study made a significant contribution to a body of work that aims to deliver a more effective treatment for pain for individuals who live with Inflammatory Bowel Disease within the next 5 - 10 years.